A CAIX Dual-Targeting Small-Molecule Probe for Noninvasive Imaging of ccRCC
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.4c00104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Chengxue He und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical College, Guizhou University, Guiyang 550025, China. Hauptthemen laut MEDLINE: Carbonic Anhydrase IX, Carcinoma, Renal Cell, Gallium Radioisotopes, Kidney Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Beijing Municipal Medical Research Institute.
Abstract (Originalsprache)
Carbonic anhydrase IX (CAIX), a zinc metal transmembrane protein, is highly expressed in 95% of clear cell renal cell carcinomas (ccRCCs). A positron emission tomography (PET) probe designed to target CAIX in nuclear medicine imaging technology can achieve precise positioning, is noninvasive, and can be used to monitor CAIX expression in lesions in real time. In this study, we constructed a novel acetazolamide dual-targeted small-molecule probe [68Ga]Ga-LF-4, which targets CAIX by binding to a specific amino acid sequence. After attenuation correction, the radiolabeling yield reached 66.95 ± 0.57% (n = 5) after 15 min of reaction and the radiochemical purity reached 99% (n = 5). [68Ga]Ga-LF-4 has good in vitro and in vivo stability, and in vivo safety and high affinity for CAIX, with a Kd value of 6.62 nM. Moreover, [68Ga]Ga-LF-4 could be quickly cleared from the blood in vivo. The biodistribution study revealed that the [68Ga]Ga-LF-4 signal was concentrated in the heart, lung, and kidney after administration, which was the same as that observed in the micro-PET/CT study. In a ccRCC patient-derived xenograft (PDX) model, the signal significantly accumulated in the tumor after administration, where it was retained for up to 4 h. After competitive blockade with LF-4, uptake at the tumor site was significantly reduced. The SUVmax of the probe [68Ga]Ga-LF-4 at the ccRCC tumor site was three times greater than that in the PC3 group with low CAIX expression at 30 min (ccRCC vs PC3:1.86 ± 0.03 vs 0.62 ± 0.01, t = 48.2, P < 0.0001). These results indicate that [68Ga]Ga-LF-4 is a novel small-molecule probe that targets CAIX and can be used to image localized and metastatic ccRCC lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical College, Guizhou University, Guiyang 550025, China.
- State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceu…
- Department of Orthopedics, Guizhou Provincial People's Hospital,Anshun550002, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Beijing Municipal Medical Research Institute
- Science Foundation of Peking University Cancer Hospital
- Beijing Hospital Authority Dengfeng project
Zitieren
APA
He, C., Liu, F., Tao, J., Wang, Z., Liu, J., Liu, S., Xu, X., Li, L., Wang, F., Yang, X., Zhu, H., & Yang, Z. (2024). A CAIX Dual-Targeting Small-Molecule Probe for Noninvasive Imaging of ccRCC. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00104
Vancouver
He C, Liu F, Tao J, Wang Z, Liu J, Liu S, et al. A CAIX Dual-Targeting Small-Molecule Probe for Noninvasive Imaging of ccRCC. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00104
BibTeX
@article{He2024,
author = {He, Chengxue and Liu, Futao and Tao, Jinping and Wang, Zilei and Liu, Jiayue and Liu, Song and Xu, Xiaoxia and Li, Liqiang and Wang, Feng and Yang, Xianteng and Zhu, Hua and Yang, Zhi},
title = {A CAIX Dual-Targeting Small-Molecule Probe for Noninvasive Imaging of ccRCC},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.4c00104}
}
EUVIMED